I agree that we are running out of time with the cash that is left but this announcement is very promising due to Germany being both a wealthy country and one of the higher incidence of pancreatic cancer in Europe with over 20,000 cases per year. If 25% of cases are unresectable that means 5,000 patients per year that can benefit from the device. We just have to hope that the hospitals can negotiate for funding before we run out of money.
- Forums
- ASX - By Stock
- OSL
- Ann: 84 German hospitals can negotiate fee for Oncosil device
Ann: 84 German hospitals can negotiate fee for Oncosil device, page-17
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
Add OSL (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $49.19M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $86.34K | 6.641M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 5710300 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 5710300 | 0.012 |
14 | 8353935 | 0.011 |
16 | 7770000 | 0.010 |
12 | 7129930 | 0.009 |
7 | 10487600 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 8759385 | 11 |
0.015 | 9000000 | 4 |
0.016 | 3848170 | 5 |
0.017 | 5088882 | 2 |
0.018 | 1903748 | 4 |
Last trade - 15.21pm 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
OSL (ASX) Chart |